Ji-Wang Chern

This inventor holds 15 USPTO granted patents and 5 EPO patents. Top assignees: Annji Pharmaceutical Co., Ltd., National Science Council, Development Center for Biotechnology. Active years: 1990-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji-Wang Chern. Retrieved from https://idiyas.com/inventor/ji-wang-chern

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 66.7

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 45(Granted Patents)

Company Filing History:

6 out of 7

Annji Pharmaceutical Co., Ltd.

patents

6 out of 544

National Science Council

patents

1 out of 97

Development Center for Biotechnology

patents

4. 1 out of 16

Medical and Pharmaceutical Industry Technology and Development Center

patents

5. 1 out of 7

Purzer Pharmaceutical Co., Ltd.

patents

6. 1 out of 834,597

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11535598 - Histone deacetylases (HDACs) inhibitors (2022-12-27),

2. 9387209 - Histone deacetylases (HDACs) inhibitors (2016-07-12),

3. 9302992 - Multifunctional quinoline derivatives as anti-neurodegenerative agents (2016-04-05),

4. 9155739 - Histone deacetylases (HDACs) inhibitors (2015-10-13),

5. 8969361 - Cyclopropanecarboxylate esters of purine analogues (2015-03-03),

6. 8946282 - Indolin-2-one derivatives as protein kinase inhibitors (2015-02-03),

7. 8173693 - Benzenesulfonamide derivatives and pharmaceutical composition thereof (2012-05-08),

8. 6946470 - Method of treating psychosis in a patient (2005-09-20),

9. 6043367 - Proactive antitumor compounds (2000-03-28),

10. 5942546 - Sulfonyl-N-hydroxyguanidine derivatives (1999-08-24),

11. 5932584 - Optically active 2,3-dihydroimidazo(1,2-C) quinazoline derivatives, the (1999-08-03),

12. 5512677 - 3-substituted methyl-2,3-dihydroimidazo 1,2-c!quinazoline derivatives, (1996-04-30),

13. 5340814 - 3-substituted methyl-2,3-dihydroimidazo[1,2-C] quinazoline derivatives, (1994-08-23),

14. 5158953 - 2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (1992-10-27),

15. 4929728 - Process for preparing 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone (1990-05-29),

Title: The Innovative Journey of Ji-Wang Chern

Introduction: Ji-Wang Chern, a pioneering inventor hailing from Taipei, Taiwan, has made significant contributions to the world of technology through his groundbreaking innovations and patents.

Latest Patents: Ji-Wang Chern's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power efficiency and energy storage solutions.

Career Highlights: With a career spanning over two decades, Ji-Wang Chern has established himself as a leading figure in the tech industry, with a strong focus on sustainability and environmental impact. His work has been recognized globally for its ingenuity and practical applications.

Collaborations: Throughout his career, Ji-Wang Chern has collaborated with various research institutions, universities, and tech companies to further develop and implement his innovative ideas. His collaborative efforts have led to the successful commercialization of several patented technologies.

Conclusion: Ji-Wang Chern's relentless pursuit of innovation and commitment to creating a more sustainable future have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of inventors and shape the landscape of technological advancements worldwide.

Profile summary based on public USPTO records.